Nordlandssykehuset HF — Clinical Trial Site

34 Registered trials

18 Currently recruiting

Organisation

Nordlandssykehuset HF

Location

Bodo, Norway

Identifier

ORG-100044267

Address

Parkveien 95, 8005, Norway

Departments

Avdeling for kreft og lindrende behandling
Barnepoliklinikken
Department of Cancer
Department of Cancer and Palliative Care
Department of Cardiology
Department of Infectious Diseases
Department of Nephrology
Department of Neurology
Department of Oncology
Department of Rheumatology, Medical clinic
Dept. of Neurology
Dept. of Oncology
Dermatology
Hematologisk avdeling
Hematology
Hjerteavdelingen
Kardiologisk avdeling
Medisinsk avdeling
Medisinsk avdeling, medisinsk poliklinikk K3
medisinsk poliklinikk K3
Neurology
Nordland Hospital Bodø
Nordlandssykehuset HF
Oncology
Pediatrics
Rheumatology department
Stroke

Clinical trials at this site (34)

Search interface

A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
A Phase III Study to assess efficacy, safety, and tolerability of Zibotentan combined with Dapagliflozin, compared to Dapagliflozin, in pati… Ended

2023-504124-26-00 Chronic Kidney Disease and High Proteinuria 5 2024-04-04
Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with exten… Ended

2023-505514-15-00 Small-cell lung cancer, extensive stage 5 2022-01-11
Ocrelizumab VErsus Rituximab off-Label at the Onset of Relapsing MS Disease (OVERLORD-MS) Ended

2024-510716-71-00 Multiple Sclerosis 5 2020-10-21
A clinical study of MK-0616 for people with high amounts of low-density lipoprotein cholesterol Ended

2022-502782-14-00 Heterozygous Familial Hypercholesterolemia (HeFH) 5 2023-09-28
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
An efficacy and safety study of HRO350 in patients with mild-to-moderate psoriasis (the ‘HeROPA’ study) Ended

2022-501850-12-00 Psoriasis 4 2023-03-15
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
The MiBlock study Ended

2024-515165-34-00 Chronic migraine 5 2019-10-01